| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.7M | +14.7% | +29.0% |
| R&D Expense | $1.6M | +16.4% | +2.9% |
| SG&A Expense | $5.1M | +31.7% | +43.7% |
| Operating Income | $440K | -61.1% | -61.7% |
| Pre-tax Income | $607K | -56.1% | -50.0% |
| Income Tax | $29K | — | -34.1% |
| Net Income | $578K | -52.5% | -50.6% |
| EPS (Basic) | $0.02 | -50.0% | -50.0% |
| EPS (Diluted) | $0.02 | -50.0% | -50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $6.4M | +29.7% | +57.0% |
| Inventory | $1.2M | +157.7% | +103.1% |
| Current Assets | $23.0M | -45.0% | -23.6% |
| Total Assets | $91.3M | +17.5% | +35.3% |
| Current Liabilities | $16.8M | +36.2% | +51.0% |
| Total Liabilities | $18.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.0M | — | +64.5% |
| Investing Cash Flow | -$26.2M | — | — |
| Financing Cash Flow | $61K | — | -96.5% |
| +51.9% |
| Stockholders' Equity | $72.7M | +13.9% | +31.7% |